By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Morphotek Inc. 

210 Welsh Pool Road

Exton  Pennsylvania  19341  U.S.A.
Phone: 610-423-6100 Fax: n/a


Company News
Morphotek Inc. Announces Initiation Of Farletuzumab Study In Patients With First-Relapsed, Platinum-Sensitive Ovarian Cancer With Low Levels Of The Immunosuppressive CA125 Tumor Antigen 3/30/2015 9:02:15 AM
Morphotek Inc. And Sorrento Therapeutics, Inc. Sign An Exclusive Research And Option Agreement To Generate And Develop Morphotek Antibody Drug Conjugates 6/25/2014 7:04:46 AM
Morphotek Inc. Announces Initiation of a New MORAb-004 Phase I Study in Pediatric Patients With Relapsed/Refractory Solid Tumors 10/9/2013 10:24:06 AM
Morphotek Inc. Achieves LEED® Certification for New Pilot Plant 7/8/2013 9:22:19 AM
Morphotek Inc. Announces Initiation of a Phase I Study for MORAb-066 6/25/2013 10:47:51 AM
Morphotek Inc. Pilot Plant Receives 2013 Facility of the Year Award 2/4/2013 10:13:48 AM
Morphotek Inc. farletuzumab Phase 3 Study Fails to Meet Primary Endpoint 1/11/2013 7:12:21 AM
FDA Grants Orphan Drug Status to FDA's Amatuximab (MORAb-009) 11/12/2012 9:50:39 AM
Morphotek Inc. Announces Initiation of MORAb-004 Phase II Study in Metastatic Soft Tissue Sarcoma 8/27/2012 9:50:37 AM
Morphotek Inc. Opens 60,000-Square-Foot Manufacturing Plant 8/15/2012 10:41:36 AM